Stay updated on Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.

Latest updates to the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed from the page header.SummaryDifference0.0%

- Check22 days agoChange Detected- Revision updated to v3.3.1 from v3.2.0; this appears to be a backend version update with no visible changes to study content or layout.SummaryDifference0.0%

- Check29 days agoChange DetectedRemoved a generic government funding status notice from the ClinicalTrials.gov page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedNo additions or deletions were detected on the Study Details page for NCT04210843.SummaryDifference0.1%

- Check72 days agoChange Detected- Added a government funding notice and operating status details (critical for user awareness). - Bumped version from v3.1.0 to v3.2.0 (metadata-level update).SummaryDifference1%

- Check79 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.0%

Stay in the know with updates to Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.